Skip Navigation

Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: Weighing the Options


This tool is an online continuing education program (CME) for physicians, nurse practitioners, physician assistants, pharmacists, nurses, case managers, health educators, and medical assistants. The course addresses key findings and clinical applications from a systematic review of comparative risks and benefits of therapies for clinically localized prostate cancer. This CME activity covers the core competencies and educational needs for medical knowledge, practice-based learning and improvement, and system-based practice.

At the conclusion of this activity, the participant should be able to:
  • Describe the efficacy and safety of treatment options for preventing biochemical progression, inhibiting metastasis, and prolonging survival
  • Summarize the influences of patient, tumor, and provider/hospital characteristics on treatment outcomes
  • Apply the findings in clinical settings to help patients make informed decisions about treatment options


PRIME Education, Inc.

Funding Sources

Agency for Healthcare Research and Quality; U.S. Department of Health and Human Services

QualityTool Topic



  • Release Date: 08/2011
  • Original Summary: 11/2011
Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.
QualityTool Classification
Disease/Clinical Category:
IOM Domains of Quality:

Last updated: July 18, 2012.